Teva sharpens ax, preps brutal cuts in R&D and across the group in face of crushing debt
The word out of Israel today is that Teva is prepping a round of brutal cuts, with plans to shutter an R&D center and lay off up to 10,000 staffers.
The R&D center is in Netanya in Israel. Calcalist is also reporting that the company will sell off a logistics center as it looks to slash up to $2 billion in costs in the next two years in the face of crushing debt payments.
Teva already recently announced that R&D chief Michael Hayden is leaving the company after 5 years, signaling big changes for its research operation.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.